PUMA BIOTECHNOLOGY, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 40.64 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-03
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 39.29M shares, a 2.10% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 39.04M shares, a 2.21% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 38.89M shares, a 2.24% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 38.65M shares, a 2.19% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 40.64M shares, a 2.69% increase from fiscal 2020.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 39.58M shares, a 2.08% increase from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 38.77M shares, a 2.18% increase from fiscal 2018.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 37.94M shares, a 2.08% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | 40.64M shares 10-K · filed 2022-03-03 | ||||
| 2020-12-31 | 39.58M shares 10-K · filed 2022-03-03 | ||||
| 2020-03-31 | 39.29M shares 10-Q · filed 2020-05-07 | 39.17M shares derived: average of 2 quarters · filed 2021-03-01 | 39.08M shares derived: average of 3 quarters · filed 2021-03-01 | 38.97M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2019-12-31 | 39.04M shares 10-K · filed 2021-03-01 | 38.97M shares derived: average of 2 quarters · filed 2021-03-01 | 38.86M shares derived: average of 3 quarters · filed 2021-03-01 | 38.77M shares 10-K · filed 2022-03-03 | |
| 2019-09-30 | 38.89M shares 10-K · filed 2021-03-01 | 38.77M shares derived: average of 2 quarters · filed 2021-03-01 | 38.68M shares 10-Q · filed 2019-11-07 | 38.56M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | 38.65M shares 10-K · filed 2021-03-01 | 38.57M shares 10-Q · filed 2019-08-09 | 38.44M shares derived: average of 3 quarters · filed 2021-03-01 | 38.34M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | 38.48M shares 10-K · filed 2021-03-01 | 38.34M shares derived: average of 2 quarters · filed 2021-03-01 | 38.24M shares derived: average of 3 quarters · filed 2021-03-01 | 38.14M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | 38.20M shares 10-K · filed 2021-03-01 | 38.12M shares derived: average of 2 quarters · filed 2021-03-01 | 38.02M shares derived: average of 3 quarters · filed 2021-03-01 | 37.94M shares 10-K · filed 2021-03-01 | |
| 2018-09-30 | 38.04M shares 10-K · filed 2021-03-01 | 37.93M shares derived: average of 2 quarters · filed 2021-03-01 | 37.86M shares 10-Q · filed 2019-11-07 | 37.77M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2018-06-30 | 37.82M shares 10-K · filed 2021-03-01 | 37.76M shares 10-Q · filed 2019-08-09 | 37.68M shares derived: average of 3 quarters · filed 2021-03-01 | 37.57M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2018-03-31 | 37.70M shares 10-K · filed 2021-03-01 | 37.62M shares derived: average of 2 quarters · filed 2021-03-01 | 37.48M shares derived: average of 3 quarters · filed 2021-03-01 | 37.36M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2017-12-31 | 37.53M shares 10-K · filed 2020-02-28 | 37.37M shares derived: average of 2 quarters · filed 2020-02-28 | 37.25M shares derived: average of 3 quarters · filed 2020-02-28 | 37.17M shares 10-K · filed 2020-02-28 | |
| 2017-09-30 | 37.21M shares 10-K · filed 2020-02-28 | 37.10M shares derived: average of 2 quarters · filed 2020-02-28 | 37.05M shares 10-Q · filed 2018-11-05 | 36.71M shares derived: average of 4 quarters · filed 2020-02-28 | |
| 2017-06-30 | 36.99M shares 10-K · filed 2020-02-28 | 36.96M shares 10-Q · filed 2018-08-09 | 36.54M shares derived: average of 3 quarters · filed 2020-02-28 | 35.53M shares derived: average of 4 quarters · filed 2020-02-28 | |
| 2017-03-31 | 36.93M shares 10-K · filed 2020-02-28 | 36.31M shares derived: average of 2 quarters · filed 2020-02-28 | 35.04M shares derived: average of 3 quarters · filed 2020-02-28 | 34.40M shares derived: average of 4 quarters · filed 2020-02-28 | |
| 2016-12-31 | 35.69M shares 10-K · filed 2019-03-01 | 34.10M shares derived: average of 2 quarters · filed 2019-03-01 | 33.56M shares derived: average of 3 quarters · filed 2019-03-01 | 33.30M shares 10-K · filed 2019-03-01 | |
| 2016-09-30 | 32.50M shares 10-K · filed 2019-03-01 | 32.50M shares derived: average of 2 quarters · filed 2019-03-01 | 32.49M shares 10-Q · filed 2017-11-09 | 32.48M shares derived: average of 4 quarters · filed 2019-03-01 | |
| 2016-06-30 | 32.49M shares 10-K · filed 2019-03-01 | 32.49M shares 10-Q · filed 2017-08-09 | 32.47M shares derived: average of 3 quarters · filed 2019-03-01 | 32.43M shares derived: average of 4 quarters · filed 2019-03-01 | |
| 2016-03-31 | 32.48M shares 10-K · filed 2019-03-01 | 32.46M shares derived: average of 2 quarters · filed 2019-03-01 | 32.41M shares derived: average of 3 quarters · filed 2019-03-01 | 32.35M shares derived: average of 4 quarters · filed 2019-03-01 | |
| 2015-12-31 | 32.44M shares 10-K · filed 2018-03-09 | 32.37M shares derived: average of 2 quarters · filed 2018-03-09 | 32.30M shares derived: average of 3 quarters · filed 2018-03-09 | 32.13M shares 10-K · filed 2018-03-09 | |
| 2015-09-30 | 32.30M shares 10-K · filed 2018-03-09 | 32.23M shares derived: average of 2 quarters · filed 2018-03-09 | 32.02M shares 10-Q · filed 2016-11-09 | 31.57M shares derived: average of 4 quarters · filed 2018-03-09 | |
| 2015-06-30 | 32.16M shares 10-K · filed 2018-03-09 | 31.87M shares 10-Q · filed 2016-08-09 | 31.33M shares derived: average of 3 quarters · filed 2018-03-09 | 31.02M shares derived: average of 4 quarters · filed 2018-03-09 | |
| 2015-03-31 | 31.59M shares 10-K · filed 2018-03-09 | 30.91M shares derived: average of 2 quarters · filed 2018-03-09 | 30.65M shares derived: average of 3 quarters · filed 2018-03-09 | 30.51M shares derived: average of 4 quarters · filed 2018-03-09 | |
| 2014-12-31 | 30.23M shares 10-K · filed 2017-03-01 | 30.18M shares derived: average of 2 quarters · filed 2017-03-01 | 30.16M shares derived: average of 3 quarters · filed 2017-03-01 | 30.01M shares 10-K · filed 2017-03-01 | |
| 2014-09-30 | 30.12M shares 10-K · filed 2017-03-01 | 30.12M shares derived: average of 2 quarters · filed 2017-03-01 | 29.94M shares 10-Q · filed 2015-11-09 | 29.64M shares derived: average of 4 quarters · filed 2017-03-01 | |
| 2014-06-30 | 30.12M shares 10-K · filed 2017-03-01 | 29.84M shares 10-Q · filed 2015-08-10 | 29.48M shares derived: average of 3 quarters · filed 2017-03-01 | 29.28M shares derived: average of 4 quarters · filed 2017-03-01 | |
| 2014-03-31 | 29.57M shares 10-K · filed 2017-03-01 | 29.16M shares derived: average of 2 quarters · filed 2017-03-01 | 29.00M shares derived: average of 3 quarters · filed 2017-03-01 | 28.92M shares derived: average of 4 quarters · filed 2017-03-01 | |
| 2013-12-31 | 28.75M shares 10-K · filed 2016-02-29 | 28.72M shares derived: average of 2 quarters · filed 2016-02-29 | 28.70M shares derived: average of 3 quarters · filed 2016-02-29 | 28.70M shares 10-K · filed 2016-02-29 | |
| 2013-09-30 | 28.68M shares 10-K · filed 2016-02-29 | 28.68M shares derived: average of 2 quarters · filed 2016-02-29 | 28.68M shares 10-Q · filed 2014-11-10 | 28.14M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2013-06-30 | 28.68M shares 10-K · filed 2016-02-29 | 28.68M shares 10-Q · filed 2014-08-11 | 27.95M shares derived: average of 3 quarters · filed 2016-02-29 | 25.98M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2013-03-31 | 28.68M shares 10-K · filed 2016-02-29 | 27.59M shares derived: average of 2 quarters · filed 2016-02-29 | 25.08M shares derived: average of 3 quarters · filed 2016-02-29 | 23.82M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2012-12-31 | 26.51M shares 10-K · filed 2015-03-02 | 23.28M shares derived: average of 2 quarters · filed 2015-03-02 | 22.20M shares derived: average of 3 quarters · filed 2015-03-02 | 21.73M shares 10-K · filed 2015-03-02 | 21.73B shares 10-K · filed 2013-04-01 |
| 2012-09-30 | 20.04M shares 10-K · filed 2015-03-02 | 20.04M shares derived: average of 2 quarters · filed 2015-03-02 | 20.04M shares 10-Q · filed 2013-11-12 | 19.78M shares derived: average of 4 quarters · filed 2015-03-02 | |
| 2012-06-30 | 20.04M shares 10-K · filed 2015-03-02 | 20.04M shares 10-Q · filed 2013-08-06 | 19.69M shares derived: average of 3 quarters · filed 2015-03-02 | 15.77M shares derived: average of 4 quarters · filed 2015-03-02 | |
| 2012-03-31 | 20.04M shares 10-K · filed 2015-03-02 | 19.51M shares derived: average of 2 quarters · filed 2015-03-02 | 14.34M shares derived: average of 3 quarters · filed 2015-03-02 | 11.76M shares derived: average of 4 quarters · filed 2015-03-02 | |
| 2011-12-31 | 18.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | 11.49M shares derived: average of 2 quarters · filed 2014-03-03 | 9.00M shares derived: average of 3 quarters · filed 2014-03-03 | 7.75M shares 10-K · filed 2014-03-03 | 7.75B shares 10-K · filed 2013-04-01 |
| 2011-09-30 | 4.00M shares 10-Q · filed 2012-11-14 | 4.00M shares derived: average of 2 quarters · filed 2012-11-14 | 4.00M shares 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | 4.00M shares 10-Q · filed 2012-08-14 | 4.00M shares 10-Q · filed 2012-08-14 | |||
| 2010-12-31 | 4.00B shares 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |